Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
Adial Pharmaceuticals NASDAQ ADIL
$1.76 0.06 3.41%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 21 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

2.07M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-752.86K
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
0.67
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
1.18M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-5.38 %
Upcoming events Adial Pharmaceuticals All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Adial Pharmaceuticals

Stock analysis Adial Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.34 35.52
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.51 13.63
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
0.08 17.42
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.31 0.37
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-258.83 8.90

Price change Adial Pharmaceuticals per year

1.65$ 5.08$
Min Max

Summary analysis Adial Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Adial Pharmaceuticals

Revenue and net income Adial Pharmaceuticals

All parameters
Stock news Adial Pharmaceuticals All news
10 April в 17:45

Adial Pharmaceuticals Shares Rise 78% After Positive Trial Data for AD04

11 July 2023 в 17:55

Adial Pharmaceuticals Shares Nearly Double After FDA Feedback

11 July 2023 в 17:50

Adial Pharmaceuticals Shares Nearly Double After FDA Feedback

6 September 2022 в 16:27

Adial Pharmaceuticals Sees Positive Data in Trial for PNV-6005

6 September 2022 в 16:27

Adial Pharmaceuticals Sees Positive Data in Trial for PNV-6005

17 August 2022 в 14:23

ADial Pharmaceuticals downgraded to hold from buy at Maxim Group

24 January 2022 в 17:40

Adial Pharmaceuticals Gets Notice of Allowance for AD04 Patent Application

24 January 2022 в 17:40

Adial Pharmaceuticals Gets Notice of Allowance for AD04 Patent Application

About company Adial Pharmaceuticals

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in phase 3 clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Charlottesville, Virginia.
Address:
1180 Seminole Trail, Charlottesville, VA, United States, 22901
Company name: Adial Pharmaceuticals
Issuer ticker: ADIL
ISIN: US00688A1060
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2018-07-30
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.adialpharma.com

On which stock exchange are Adial Pharmaceuticals (ADIL) stocks traded?

Adial Pharmaceuticals (ADIL) stocks are traded on NASDAQ.

What is the ticker of Adial Pharmaceuticals stocks (ADIL)?

The stock ticker of Adial Pharmaceuticals’s stocks or in other words, the code is ADIL. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Adial Pharmaceuticals (ADIL) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Adial Pharmaceuticals (ADIL) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Adial Pharmaceuticals (ADIL) stocks traded?

Adial Pharmaceuticals (ADIL) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Adial Pharmaceuticals (ADIL) stocks today?

The current price of Adial Pharmaceuticals stocks on 02.05.2024 is 1.76 dollars. per share.

What is the dynamics of Adial Pharmaceuticals (ADIL) stocks from the beginning of the year?

Adial Pharmaceuticals (ADIL) quotes have increased by 0.57% from the beginning of the year up to 1.76 dollars. per 1 stocks.

How much did Adial Pharmaceuticals (ADIL) stocks increase in мае 2024?

This month Adial Pharmaceuticals (ADIL) quotes have increased by 0% to 1.76 dollars. per share.

How much are Adial Pharmaceuticals (ADIL) stocks worth?

Today, on October, 02.05.2024 Adial Pharmaceuticals’s (ADIL) stocks cost 1.76 dollars..

What is the market capitalization of Adial Pharmaceuticals (ADIL)?

Capitalization is the market value of Adial Pharmaceuticals (ADIL) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 02.05.2024, the market capitalization of Adial Pharmaceuticals (ADIL) is estimated at about 2074225 dollars.